What is Ataraxis AI?
Ataraxis AI is at the forefront of AI precision medicine, dedicated to equipping physicians with sophisticated tools designed to identify the most effective treatment pathways. By enhancing diagnostic accuracy and treatment selection, the company aims to significantly improve patient outcomes and drive advancements in healthcare. The company's focus on leveraging artificial intelligence for personalized medical solutions positions it as a key innovator in the rapidly evolving health-tech sector.
How much funding has Ataraxis AI raised?
Ataraxis AI has raised a total of $24.4M across 2 funding rounds:
Angel/Seed
$4M
Series A
$20.4M
Angel/Seed (2024): $4M with participation from The Obvious and Giant Ventures
Series A (2025): $20.4M led by Bertelsmann Investments, Obvious Ventures, Giant Ventures, AIX Ventures, Founders Fund, Floating Point Group, and Thiel Bio
Key Investors in Ataraxis AI
Bertelsmann Investments
Bertelsmann Investments is a global investment platform focused on driving returns and fostering entrepreneurship across various sectors and stages. With a history dating back to 1835, it manages several billion in assets and partners with leading entrepreneurs and venture funds worldwide.
Obvious Ventures
The Obvious Corp is a full-service creative and design firm that transforms client ideas into compelling marketing and communications materials across multiple formats and channels. The company specializes in strategic design, copywriting, and illustration services.
Giant Ventures
Giant Ventures is a venture capital firm that supports ambitious founders leveraging technology to transform civilization. They invest in companies from Pre-Seed to Growth stages across Europe and the US.
What's next for Ataraxis AI?
The substantial capital raised, particularly the recent major strategic investment, signals Ataraxis AI's readiness to scale its operations and accelerate product development. This funding will likely be instrumental in expanding its research and development capabilities, forging strategic partnerships within the healthcare ecosystem, and broadening its market reach. The company is poised to further solidify its position as a leader in AI-driven precision medicine, driving innovation that directly impacts patient care and health outcomes.
See full Ataraxis AI company page
